Results 61 to 70 of about 734 (134)

Teixobactin: A Novel Antibiotic in Treatment of Gram Positive Bacterial Infections [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Arunava Kali
doaj   +1 more source

Visualizing Teixobactin Supramolecular Assemblies and Cell Wall Damage in B. Subtilis Using CryoEM

open access: yesACS Omega, 2021
Paul Joshua Hurst   +4 more
doaj   +1 more source

SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIP OF TEIXOBACTIN ANALOGUES [PDF]

open access: yes
Multi-drug resistant bacteria that are primarily unresponsive towards the available marketed antibiotics presents a threat to global health, leading to an increase in mortality and morbidity rate. Today, more than 700,000 people die annually as a consequence to the bacterial infections. This number is expected to rise to 10 million by 2050.
openaire   +1 more source

Synthesis of Teixobactin Analogues and their Biological Evaluation

open access: yes, 2019
The work herein is part of my PhD for four years (April 2015- October 2018) at Lincoln University, UK. I have had the opportunity to travel to Temple University, Philadelphia, the USA, to advance my techniques and work on other collaborated projects.
openaire   +2 more sources

Simplified teixobactin analogues to target superbugs

open access: yes, 2018
Ishwar Singh speaks to Benjamin Walden, Commissioning Editor. Ishwar Singh is a Senior Lecturer in biological chemistry at the School of Pharmacy, University of Lincoln. Prior to Lincoln, he had held many prestigious fellowships such as the Alexander von Humboldt fellowship, Germany; and Senior Research Fellowship, DANIDA, Denmark and CSIR, India.
Ishwar Singh, Benjamin Walden
openaire   +1 more source

Prolonged exposure to teixobactin generates cross-tolerance to other cell wall-targeting antimicrobials in <i>Enterococcus faecalis</i>. [PDF]

open access: yesAntimicrob Agents Chemother
Darnell RL   +10 more
europepmc   +1 more source

Synthesis and Stereochemical Determination of the Peptide Antibiotic Novo29. [PDF]

open access: yesJ Org Chem, 2023
Krumberger M   +10 more
europepmc   +1 more source

Novltex: A New Class of Antibiotics with Potent Activity against Multidrug-Resistant Bacterial Pathogens─Design, Synthesis, and Biological Evaluation. [PDF]

open access: yesJ Med Chem
Malkawi E   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy